CardioCube: COVID AI-driven conversational agent
CardioCube COVID enables virtual care for patients with coronavirus and quarantined individuals using AI-driven conversational agents deployed on smartphones and smart speakers. Automatic forward triage system allows to multiply healthcare provider's workforce increasing patients and providers safety thorough physical distancing. CardioCube COVID will include following modules: 1. Clinical Follow-Up - periodically, using mobile or voice interface, user answers a set of clinical questions to evaluate the health status at home. CardioCube red-flags patients/quarantined individuals at-r...
Xcope - Corona-Home-Control
The project is to develop an app that allows people to communicate with quarantined doctors. So you don't have to leave home if you have symptoms of a coronavirus and don't infect other people. We are building a stethoscope for the smartphone so that they can auscultate their lungs and also send it to their doctor. If we have enough data, we can also build machine learning or deep learning models to automatically detect when the coronavirus is causing pneumonia (then it becomes dangerous). This allowed people to be treated at home and only go to a hospital if the disease worsened.
In a nutshell: Communication4Care (Com4Care) is a cloud-based communication platform to facilitate GDPR conform interoperability and link of relevant (sensor) data with structured patient-related information. No data files need to be exchanged and the platform provides a secure data storage and (real time or asynchronous) communication channel. Thus, improved standardized data acquisition, process monitoring, and data interpretation are possible. The patient can collect and report individual findings and outcomes (PROMs) and 'distribution of information' or sending of data files (electronic...
Innovative end-to-end solution for respiratory diseases detection and genotyping
Our innovative end-to-end solution for respiratory diseases detection and genotyping is composed of 3 main compoenets as follows: First, we want, through a multiplex qPCR assay, to target and differentiate in priority COVID-19, SARS, H5N1, H1N1 (devastating diseases) from seasonal flu (under control). Second, we propose to develop an NGS and SANGER assay for the following Intended uses: Respiratory diseases Genotyping, Screening, Monitoring, Quasispecies identification, Epidemiological studies. Third, we target to establish a large COVID-19 and SARS worldwide database , compare patient ...